验方甲眼康治疗甲状腺相关性眼病临床研究.docVIP

验方甲眼康治疗甲状腺相关性眼病临床研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
验方甲眼康治疗甲状腺相关性眼病临床研究

验方甲眼康治疗甲状腺相关性眼病临床研究   【摘要】 目的:观察验方“甲眼康”治疗甲状腺相关性眼病的疗效。方法:将2005-2007年笔者所在医院门诊及住院的58例甲状腺相关性眼病患者,随机分为对照组28例和试验组30例。对照组进行常规的甲亢治疗,试验组在对照组的基础上加用验方“甲眼康”。观察并比较两组的治疗效果。结果:试验组总有效率为83.3%,对照组为39.3%,两组比较差异有统计学意义(P0.05)。试验组的Ⅰ级(轻度)、Ⅱ级(中度)和Ⅲ级(重度)患者的总有效率分别为100%、92.9%、33.3%;对照组分别为53.8%、33.3%、0。结论:验方“甲眼康”治疗甲状腺相关性眼病具有较好的疗效和较高的安全性,尤其是对于轻中度甲亢眼突患者。   【关键词】 疏肝解郁; 化痰散结; 养阴清热; 甲状腺相关性眼病   中图分类号 R581.9 文献标识码 B 文章编号 1674-6805(2014)15-0119-02   The Clinical Research of Prescription Jiayankang in the Treatment of Thyroid Associated Ophthalmopathy/XIE Yu-ming,LU Ji-sen,ZHOU Shao-jun,et al.//Chinese and Foreign Medical Research,2014,12(15):119-120   【Abstract】 Objective:To observe the curative effect of prescriptions Jiayankang in the treatment of thyroid associated ophthalmopathy.Method:58 cases of thyroid associated ophthalmopathy in our hospital of outpatient and hospitalization from 2005 to 2007 were randomly divided into control group 28 cases and experimental group 30 cases.The control group treated with routine treatment of hyperthyroidism,the experimental group used prescriptions Jiayankang on the basis of the control group.To observe and compare the therapeutic effect of two groups.Result:The total effective rate of experimental group was 83.3%,it was 39.3% in the control group,the difference was statistically significant(P0.05).The effective rate of class Ⅰ(mild),class Ⅱ(moderate) and the level Ⅲ(serious) in the experimental group were 100%,92.9% and 33.3% respectively,the control group were 53.8%,33.3% and 0,respectively.Conclusion:The prescription Jiayankang has a good efficacy and high safety in the treatment of thyroid associated ophthalmopathy,especially for patients with mild to moderate thyroid associated eye disease.   【Key words】 Smooth the liver and regulate the qi-flow; Reducing phlegm and resolving masses; Replenishing the vital essence and removing heat; Thyroid associated ophthalmopathy   First-author’s address:Guangzhou Liwan District Hospital of Traditional Chinese

文档评论(0)

erterye + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档